Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 183

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 183
---
 Limitation on Liability of Directors

Our Certificate of Incorporation
provides that our officers and directors will be indemnified by us to the fullest extent authorized by Delaware law, as it now exists
or may in the future be amended. In addition, our Certificate of Incorporation provides that our directors will not be personally liable
for monetary damages to us for breaches of their fiduciary duty as directors, except to the extent such exemption from liability or limitation
thereof is not permitted by the DGCL.

Our Certificate of Incorporation
also permits us to maintain insurance on behalf of any officer, director or employee for any liability arising out of his or her actions,
regardless of whether Delaware law would permit such indemnification. We have purchased a policy of directors’ and officers’
liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances
and insures us against our obligations to indemnify our officers and directors.

These provisions may discourage
stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also may have the effect
of reducing the likelihood of derivative litigation against officers and directors, even though such an action, if successful, might otherwise
benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely affected to the extent we pay the costs
of settlement and damage awards against officers and directors pursuant to these indemnification provisions.

We believe that these provisions
and the insurance are necessary to attract and retain talented and experienced officers and directors.

| 104 |

<div align='center'>EXECUTIVE COMPENSATION</div>

2024 Summary Compensation Table

The following summary compensation table provides
information regarding the compensation earned during our fiscal years ended December 31, 2024 and 2023 to certain of our executive officers,
who we collectively refer to as our “named executive officers” or “NEOs”.

| Name and Principal Position          |     | Year |      |     |     | Salary ($) |         |     | Bonus ($) |   |     | Stock Awards ($) |         |     | Option Awards ($)(1) |         |     | Non- Equity Incentive Plan Compensation ($) |   |     | Non- qualified Deferred Compensation Earnings ($) |   |     | All Other Compensation ($) |        |     |     | Total ($) |           |
|:-------------------------------------|:----|:-----|-----:|----:|:----|:-----------|